
Saint Luke's Mid America Heart Institute
@MidAmericaHeart
Followers
2K
Following
1K
Media
222
Statuses
823
Twitter home of Mid America Heart Institute, St. Luke’s Hospital of Kansas City @saintlukeskc https://t.co/Hcb1gGpaOJ
Kansas City, MO
Joined October 2018
Fellowship application season is upon us!. @UMKC and Saint Luke's @MidAmericaHeart offers:.✴️ 3 yr CV fellowship.✴️ 4 yr T32 clinical/research track.✴️ Advanced HF.✴️ EP.✴️ Interventional.✴️ Structural.✴️ CV Imaging.✴️ Prevention. Apply today!.
2
8
38
RT @BrettSperryMD: Star fellow @mirzakhan_ presenting data on geographic patterns of prescriptions for amyloid medications from EPIC Cosmos….
0
3
0
RT @AndrewJSauer: Understanding patient-reported outcomes in obstructive hypertrophic cardiomyopathy (oHCM) is vital for managing treatment….
0
17
0
RT @AndrewJSauer: At #ESCHF2025 🇷🇸 @MidAmericaHeart fellow Dr Omar Cantu-Martinez presents #CAREHKinHF real-world registry: >2,300 HF pts w….
0
4
0
RT @AndrewJSauer: Grateful for the opportunity to work with @Amgen in collaboration with @cardiometalli @MidAmericaHeart as part of the LAT….
0
2
0
RT @BrettSperryMD: Special focus issue in @JACCJournals this week on Cardiac Amyloidosis. Many important articles! Sharing my editorial wi….
0
23
0
RT @CCFcards: One of the defining aspects of our fellowship are our accomplished alumni. As a part of our fellowship research day, Dr. Chha….
0
5
0
Art Still, a former @Chiefs defensive end, has dedicated himself to increasing awareness for ATTR amyloidosis ever since his diagnosis in 2023. @TODAYshow spoke with Dr. Brett Sperry, a @MidAmericaHeart cardiologist, to discuss the rare genetic condition:
0
0
2
Outside of her work as an oncologist, Dr. Juliet Appiah helps cancer patients in her home country of Ghana. Dr. Appiah spoke with @KSHB41 about her passion for giving back to her home country and raising awareness for all types of cancer. Watch now:
0
0
2
RT @MidAmericaHeart: Here are some reasons why you should train with us in Cardiovascular Disease at the University of Missouri-Kansas City….
0
6
0
RT @AndrewJSauer: Proof I made it to @escardio . Let’s go! . Check out @JACCJournals publications our team is releasing soon during London….
0
4
0
RT @AndrewJSauer: Semaglutide and obesity related HFpEF. Patients with atrial fibrillation and obesity HFpEF are generally more burdened/co….
0
3
0
RT @AndrewJSauer: Inflammation reduction by semaglutide as measured by CRP tracks with magnitude of NTproBNP reduction. .
0
2
0
RT @AndrewJSauer: Semaglutide and obesity HFpEF. Echo markers. Improved LA volume reduction and markers of diastolic function with GLP1 com….
0
20
0
RT @AndrewJSauer: CV outcomes from FLOW trial. Semaglutide vs placebo focused on patients with HF within larger population of T2DM and CK….
0
3
0
RT @AndrewJSauer: Pooled analysis of patients with HFpEF in STEP-HFpEF, SELECT, and FLOW . @MkosiborodMD .@MidAmericaHeart .@saintlukeskc….
0
16
0
Here are some reasons why you should train with us in Cardiovascular Disease at the University of Missouri-Kansas City School of Medicine program @MidAmericaHeart @saintlukeskc!
1
6
15
RT @DeZorzi_MD: Excited to be joining Saint Luke’s Mid America Heart Institute in Kansas City to help care for ACHD patients at the only ac….
0
3
0
RT @BrettSperryMD: Healthy vs pathological microvascular aging?. New research showing myocardial blood flow reserve is higher in young male….
0
8
0
A few of our phenomenal fellows celebrating with some pickleball after surviving echo boards!. @VuppalaSuchith @AndyGodwin @AmandaHeuszel Mark Metzinger, Angel Garcia @CharlesFoxIV @DanNguyenCVO. @saintlukeskc
0
1
24